More surprisingly, intensive glycemic control (HbA1C 6.4% vs 7.5%), accomplished by more use of insulin(s) and oral drug combinations is reported to be associated with increased mortality [31], in particular in T2D patients presenting with diabetic nephropathy [36]. This evidence concerns the gene INS and type 2 diabetes mellitus.